Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on April 18, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
7,125 cr
Turnover Ratio
18.67%
Expense Ratio
0.92%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -0.52%
- 1Y: 50.49%
- 3M: 3.95%
- 3Y: 17.19%
- 6M: 20.16%
- 5Y: 23.45%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
32.200 | 57.77% | 3,772 cr | 1.04% | - | ||
388.006 | 55.50% | 2,626 cr | 0.95% | - | ||
25.464 | 44.85% | 62 cr | 1.21% | - |
Other plans of Nippon India Pharma